0001209191-16-126311.txt : 20160607 0001209191-16-126311.hdr.sgml : 20160607 20160607172457 ACCESSION NUMBER: 0001209191-16-126311 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160603 FILED AS OF DATE: 20160607 DATE AS OF CHANGE: 20160607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc CENTRAL INDEX KEY: 0001328143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421560076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-3554 MAIL ADDRESS: STREET 1: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc DATE OF NAME CHANGE: 20050524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ericson William W. CENTRAL INDEX KEY: 0001503381 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36399 FILM NUMBER: 161702109 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BLDG 3 STE 290 CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-03 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001503381 Ericson William W. C/O MOHR DAVIDOW VENTURES 3000 SAND HILL ROAD, #3-290 MENLO PARK CA 94025 1 0 1 0 Stock Option (Right to Buy) 17.03 2016-06-03 4 A 0 15000 0.00 A 2026-06-02 Common Stock 15000 15000 D The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from June 3, 2016, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date. /s/William Dawson, as Attorney-in-Fact 2016-06-07